189 related articles for article (PubMed ID: 38539027)
1. Population longitudinal analysis of Gait Profile Score and North Star Ambulatory Assessment in children with Duchenne muscular dystrophy.
Deng J; Liu F; Feng Z; Liu Z
CPT Pharmacometrics Syst Pharmacol; 2024 May; 13(5):891-903. PubMed ID: 38539027
[TBL] [Abstract][Full Text] [Related]
2. Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy.
Muntoni F; Domingos J; Manzur AY; Mayhew A; Guglieri M; ; Sajeev G; Signorovitch J; Ward SJ
PLoS One; 2019; 14(9):e0221097. PubMed ID: 31479456
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of gait in Duchenne Muscular Dystrophy: Relation of 3D gait analysis to clinical assessment.
Romano A; Favetta M; Schirinzi T; Summa S; Minosse S; D'Amico A; Catteruccia M; Petrarca M; Castelli E; Bertini E; Vasco G
Neuromuscul Disord; 2019 Dec; 29(12):920-929. PubMed ID: 31791868
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy.
Zamani G; Hosseinpour S; Ashrafi MR; Mohammadi M; Badv RS; Tavasoli AR; Akbari MG; Bereshneh AH; Malamiri RA; Heidari M
BMC Neurol; 2022 May; 22(1):162. PubMed ID: 35501714
[TBL] [Abstract][Full Text] [Related]
5. Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy.
Hibma JE; Jayachandran P; Neelakantan S; Harnisch LO
CPT Pharmacometrics Syst Pharmacol; 2023 Mar; 12(3):375-386. PubMed ID: 36718719
[TBL] [Abstract][Full Text] [Related]
6. Kinematic changes in gait in boys with Duchenne Muscular Dystrophy: Utility of the Gait Deviation Index, the Gait Profile Score and the Gait Variable Scores.
Sienko S; Buckon C; Bagley A; Fowler E; Heberer K; Staudt L; Sison-Williamson M; McDonald C; Sussman M
Gait Posture; 2023 Feb; 100():157-164. PubMed ID: 36529026
[TBL] [Abstract][Full Text] [Related]
7. Appendicular lean mass index and motor function in ambulatory patients with Duchenne muscular dystrophy.
Kiefer M; Townsend E; Goncalves C; Shellenbarger KC; Gochyyev P; Wong BL
Muscle Nerve; 2024 Aug; 70(2):226-231. PubMed ID: 38837739
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: A phase 1/2a nonrandomized trial.
Mendell JR; Sahenk Z; Lehman KJ; Lowes LP; Reash NF; Iammarino MA; Alfano LN; Lewis S; Church K; Shell R; Potter RA; Griffin DA; Hogan M; Wang S; Mason S; Darton E; Rodino-Klapac LR
Muscle Nerve; 2024 Jan; 69(1):93-98. PubMed ID: 37577753
[TBL] [Abstract][Full Text] [Related]
9. The use of the gait profile score and gait variable score in individuals with Duchenne Muscular Dystrophy.
Souza MA; Cezarani A; Lizzi EADS; Davoli GBQ; Mattiello SM; Jones R; Mattiello-Sverzut AC
J Biomech; 2020 Jan; 98():109485. PubMed ID: 31771784
[TBL] [Abstract][Full Text] [Related]
10. Gait deviations in Duchenne muscular dystrophy-Part 2. Statistical non-parametric mapping to analyze gait deviations in children with Duchenne muscular dystrophy.
Goudriaan M; Van den Hauwe M; Simon-Martinez C; Huenaerts C; Molenaers G; Goemans N; Desloovere K
Gait Posture; 2018 Jun; 63():159-164. PubMed ID: 29751322
[TBL] [Abstract][Full Text] [Related]
11. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.
Mazzone E; Vasco G; Sormani MP; Torrente Y; Berardinelli A; Messina S; D'Amico A; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Bonfiglio S; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Gasperini S; Previtali S; Napolitano S; Martinelli D; Bruno C; Vita G; Comi G; Bertini E; Mercuri E
Neurology; 2011 Jul; 77(3):250-6. PubMed ID: 21734183
[TBL] [Abstract][Full Text] [Related]
12. Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy.
Audhya I; Rogula B; Szabo SM; Feeny D; Bolatova T; Gooch K
Health Qual Life Outcomes; 2023 Jul; 21(1):76. PubMed ID: 37468890
[TBL] [Abstract][Full Text] [Related]
13. Hip kinetics during gait are clinically meaningful outcomes in young boys with Duchenne muscular dystrophy.
Heberer K; Fowler E; Staudt L; Sienko S; Buckon CE; Bagley A; Sison-Williamson M; McDonald CM; Sussman MD
Gait Posture; 2016 Jul; 48():159-164. PubMed ID: 27267770
[TBL] [Abstract][Full Text] [Related]
14. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests.
Miller NF; Alfano LN; Iammarino MA; Connolly AM; Moore-Clingenpeel M; Powers BR; Tsao CY; Waldrop MA; Flanigan KM; Mendell JR; Lowes LP
Pediatr Neurol; 2020 Dec; 113():15-20. PubMed ID: 32979653
[TBL] [Abstract][Full Text] [Related]
15. Progression of muscular co-activation and gait variability in children with Duchenne muscular dystrophy: A 2-year follow-up study.
Rinaldi M; Petrarca M; Romano A; Vasco G; D'Anna C; Bibbo D; Schmid M; Castelli E; Conforto S
Clin Biomech (Bristol, Avon); 2020 Aug; 78():105101. PubMed ID: 32652381
[TBL] [Abstract][Full Text] [Related]
16. Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy.
Mayhew AG; Cano SJ; Scott E; Eagle M; Bushby K; Manzur A; Muntoni F;
Dev Med Child Neurol; 2013 Nov; 55(11):1046-52. PubMed ID: 23909763
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls.
Mendell JR; Khan N; Sha N; Eliopoulos H; McDonald CM; Goemans N; Mercuri E; Lowes LP; Alfano LN;
J Neuromuscul Dis; 2021; 8(4):469-479. PubMed ID: 33523015
[TBL] [Abstract][Full Text] [Related]
18. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.
Mayhew A; Cano S; Scott E; Eagle M; Bushby K; Muntoni F;
Dev Med Child Neurol; 2011 Jun; 53(6):535-42. PubMed ID: 21410696
[TBL] [Abstract][Full Text] [Related]
19. The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.
Ricotti V; Ridout DA; Pane M; Main M; Mayhew A; Mercuri E; Manzur AY; Muntoni F;
J Neurol Neurosurg Psychiatry; 2016 Feb; 87(2):149-55. PubMed ID: 25733532
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Alterations in Gait Features in Growing Children With Duchenne Muscular Dystrophy.
Vandekerckhove I; Van den Hauwe M; De Beukelaer N; Stoop E; Goudriaan M; Delporte M; Molenberghs G; Van Campenhout A; De Waele L; Goemans N; De Groote F; Desloovere K
Front Hum Neurosci; 2022; 16():861136. PubMed ID: 35721358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
